259 related articles for article (PubMed ID: 31801287)
1. Re-Evaluating Biologic Pharmacotherapies that Target the Host Response during Sepsis.
Tuttle K; McDonald M; Anderson E
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801287
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory therapy for sepsis: an update.
Christaki E; Anyfanti P; Opal SM
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of sepsis.
van der Poll T
Lancet Infect Dis; 2001 Oct; 1(3):165-74. PubMed ID: 11871493
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: Novel therapeutic implications and challenges.
Hattori Y; Hattori K; Suzuki T; Matsuda N
Pharmacol Ther; 2017 Sep; 177():56-66. PubMed ID: 28232275
[TBL] [Abstract][Full Text] [Related]
5. The Critical Roles and Mechanisms of Immune Cell Death in Sepsis.
Cheng Z; Abrams ST; Toh J; Wang SS; Wang Z; Yu Q; Yu W; Toh CH; Wang G
Front Immunol; 2020; 11():1918. PubMed ID: 32983116
[TBL] [Abstract][Full Text] [Related]
6. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues.
Fry DE
Am Surg; 2012 Jan; 78(1):1-8. PubMed ID: 22273282
[TBL] [Abstract][Full Text] [Related]
7. The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis.
Murgo M; Adamson H; Boyle M
Aust Crit Care; 2003 Nov; 16(4):133-43. PubMed ID: 14692158
[TBL] [Abstract][Full Text] [Related]
8. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome.
Hall MW; Knatz NL; Vetterly C; Tomarello S; Wewers MD; Volk HD; Carcillo JA
Intensive Care Med; 2011 Mar; 37(3):525-32. PubMed ID: 21153402
[TBL] [Abstract][Full Text] [Related]
9. Definitions and pathophysiology of sepsis.
Sagy M; Al-Qaqaa Y; Kim P
Curr Probl Pediatr Adolesc Health Care; 2013; 43(10):260-3. PubMed ID: 24295606
[TBL] [Abstract][Full Text] [Related]
10. The Design of Nested Adaptive Clinical Trials of Multiple Organ Dysfunction Syndrome Children in a Single Study.
VanBuren JM; Hall M; Zuppa AF; Mourani PM; Carcillo J; Dean JM; Watt K; Holubkov R
Pediatr Crit Care Med; 2023 Dec; 24(12):e635-e646. PubMed ID: 37498156
[TBL] [Abstract][Full Text] [Related]
11. Statins in sepsis.
Dobesh PP; Swahn SM; Peterson EJ; Olsen KM
J Pharm Pract; 2010 Feb; 23(1):38-49. PubMed ID: 21507792
[TBL] [Abstract][Full Text] [Related]
12. Effects of Sequence Variations in Innate Immune Response Genes on Infectious Outcome in Trauma Patients: A Comprehensive Review.
Bronkhorst MW; Patka P; Van Lieshout EM
Shock; 2015 Nov; 44(5):390-6. PubMed ID: 26473437
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory strategies for the treatment of sepsis.
Riedemann NC; Ward PA
Expert Opin Biol Ther; 2003 Apr; 3(2):339-50. PubMed ID: 12662146
[TBL] [Abstract][Full Text] [Related]
14. Acute administration of recombinant Angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis.
David S; Park JK; Meurs Mv; Zijlstra JG; Koenecke C; Schrimpf C; Shushakova N; Gueler F; Haller H; Kümpers P
Cytokine; 2011 Aug; 55(2):251-9. PubMed ID: 21531574
[TBL] [Abstract][Full Text] [Related]
15. The sepsis induced defective aggravation of immune cells: a translational science underling chemico-biological interactions from altered bioenergetics and/or cellular metabolism to organ dysfunction.
Almalki WH
Mol Cell Biochem; 2021 Jun; 476(6):2337-2344. PubMed ID: 33586093
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome.
Dare AJ; Phillips AR; Hickey AJ; Mittal A; Loveday B; Thompson N; Windsor JA
Free Radic Biol Med; 2009 Dec; 47(11):1517-25. PubMed ID: 19715753
[TBL] [Abstract][Full Text] [Related]
17. Why have clinical trials in sepsis failed?
Marshall JC
Trends Mol Med; 2014 Apr; 20(4):195-203. PubMed ID: 24581450
[TBL] [Abstract][Full Text] [Related]
18. Targeting STAT3: A crucial modulator of sepsis.
Lei W; Liu D; Sun M; Lu C; Yang W; Wang C; Cheng Y; Zhang M; Shen M; Yang Z; Chen Y; Deng C; Yang Y
J Cell Physiol; 2021 Nov; 236(11):7814-7831. PubMed ID: 33885157
[TBL] [Abstract][Full Text] [Related]
19. Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight Sepsis.
Fang H; Jiang W; Cheng J; Lu Y; Liu A; Kan L; Dahmen U
J Immunol Res; 2015; 2015():187048. PubMed ID: 26798659
[TBL] [Abstract][Full Text] [Related]
20. Bench-to-bedside review: understanding genetic predisposition to sepsis.
Villar J; Maca-Meyer N; Pérez-Méndez L; Flores C
Crit Care; 2004 Jun; 8(3):180-9. PubMed ID: 15153236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
